wsj.com/amp/articles/pfizers-covid-19-vaccine-lifts-quarterly-results-11620130446
The pharmaceutical company boosted its full-year guidance for sales from the vaccine to $26 billion from $15 billion.
Posted by UE editors
Click to copy the Short Url to this post:
upo.st/a8tbcvqp 
The Whole Web on a Single Page, for People Who Love Good Reads. Join Now →